These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 16299679

  • 21. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
    Välimäki S, Farnebo F, Forsberg L, Larsson C, Farnebo LO.
    Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
    [Abstract] [Full Text] [Related]

  • 22. The calcium-sensing receptor and vitamin D receptor expression in tertiary hyperparathyroidism.
    Grzela T, Chudzinski W, Lasiecka Z, Niderla J, Wilczynski G, Gornicka B, Wasiutynski A, Durlik M, Boszczyk A, Brawura-Biskupski-Samaha R, Dziunycz P, Milewski L, Lazarczyk M, Lazarczyk M, Nawrot I.
    Int J Mol Med; 2006 May; 17(5):779-83. PubMed ID: 16596260
    [Abstract] [Full Text] [Related]

  • 23. [The challenge of hyperphosphatemia control in chronic kidney disease].
    Lorenzo Sellares V.
    Nefrologia; 2008 May; 28 Suppl 5():3-6. PubMed ID: 18847412
    [Abstract] [Full Text] [Related]

  • 24. Nutritional secondary hyperparathyroidism in rabbits.
    Bas S, Bas A, López I, Estepa JC, Rodríguez M, Aguilera-Tejero E.
    Domest Anim Endocrinol; 2005 May; 28(4):380-90. PubMed ID: 15826773
    [Abstract] [Full Text] [Related]

  • 25. Mechanism of parathyroid tumourigenesis in uraemia.
    Tominaga Y.
    Nephrol Dial Transplant; 1999 May; 14 Suppl 1():63-5. PubMed ID: 10048455
    [Abstract] [Full Text] [Related]

  • 26. Pathogenesis of refractory secondary hyperparathyroidism.
    Rodriguez M, Canalejo A, Garfia B, Aguilera E, Almaden Y.
    Kidney Int Suppl; 2002 May; (80):155-60. PubMed ID: 11982830
    [Abstract] [Full Text] [Related]

  • 27. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
    Wang X, Sun B, Zhou F, Hu J, Yu X, Peng T.
    Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
    [Abstract] [Full Text] [Related]

  • 28. Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management.
    Cetani F, Pardi E, Ambrogini E, Lemmi M, Borsari S, Cianferotti L, Vignali E, Viacava P, Berti P, Mariotti S, Pinchera A, Marcocci C.
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):146-52. PubMed ID: 16430712
    [Abstract] [Full Text] [Related]

  • 29. [Apoptosis in parathyroid of uremic patients with secondary hyperparathyroidism and the influence of Ca2+ and calcitriol on APO].
    Zhang P, Wei J, Han D.
    Zhonghua Nei Ke Za Zhi; 1999 Mar; 38(3):161-3. PubMed ID: 11798642
    [Abstract] [Full Text] [Related]

  • 30. [The role of calcium, calcitriol and their receptors in parathyroid regulation].
    Carrillo-López N, Fernández-Martín JL, Cannata-Andía JB.
    Nefrologia; 2009 Mar; 29(2):103-8. PubMed ID: 19396314
    [Abstract] [Full Text] [Related]

  • 31. Associations of vitamin D receptor, calcium-sensing receptor and parathyroid hormone gene polymorphisms with calcium homeostasis and peripheral bone density in adult Finns.
    Laaksonen MM, Outila TA, Karkkainen MU, Kemi VE, Rita HJ, Perola M, Valsta LM, Lamberg-Allardt CJ.
    J Nutrigenet Nutrigenomics; 2009 Mar; 2(2):55-63. PubMed ID: 19690432
    [Abstract] [Full Text] [Related]

  • 32. Parathyroid-specific deletion of dicer-dependent microRNAs abrogates the response of the parathyroid to acute and chronic hypocalcemia and uremia.
    Shilo V, Ben-Dov IZ, Nechama M, Silver J, Naveh-Many T.
    FASEB J; 2015 Sep; 29(9):3964-76. PubMed ID: 26054367
    [Abstract] [Full Text] [Related]

  • 33. [Effect of calcium on N-terminal truncation of PTH in human parathyroid cells].
    Kawata T, Imanishi Y, Kobayashi K, Tahara H, Ishimura E, Inaba M, Nishizawa Y, Takemoto Y, Onoda N, Okuno S, Ishikawa T.
    Clin Calcium; 2005 Sep; 15 Suppl 1():98-100; discussion 100-1. PubMed ID: 16279017
    [Abstract] [Full Text] [Related]

  • 34. [What are the actual indications for a surgical parathiroidectomy?].
    Torres PU.
    Nephrol Ther; 2005 Dec; 1 Suppl 4():S342-50. PubMed ID: 17373206
    [Abstract] [Full Text] [Related]

  • 35. New therapies for uremic secondary hyperparathyroidism.
    Torres PU, Prié D, Beck L, Friedlander G.
    J Ren Nutr; 2006 Apr; 16(2):87-99. PubMed ID: 16567265
    [Abstract] [Full Text] [Related]

  • 36. Parathyroid hormone regulation in normal and uremic rats. Reversibility of secondary hyperparathyroidism after experimental kidney transplantation.
    Lewin E.
    Dan Med Bull; 2004 May; 51(2):184-206. PubMed ID: 16009056
    [No Abstract] [Full Text] [Related]

  • 37. [Population genetic correlation of vitamin D receptor polymorphisms with clinical disorders].
    Gyórffy B, Szabó A, Vásárhelyi B.
    Orv Hetil; 2003 Oct 12; 144(41):2011-5. PubMed ID: 14631893
    [Abstract] [Full Text] [Related]

  • 38. Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease.
    Cozzolino M, Ciceri P, Volpi EM, Olivi L, Messa PG.
    Blood Purif; 2009 Oct 12; 27(4):338-44. PubMed ID: 19295196
    [Abstract] [Full Text] [Related]

  • 39. Progression of secondary hyperparathyroidism involves deregulation of genes related to DNA and RNA stability.
    Santamaría I, Alvarez-Hernández D, Jofré R, Polo JR, Menárguez J, Cannata-Andía JB.
    Kidney Int; 2005 Jun 12; 67(6):2267-79. PubMed ID: 15882268
    [Abstract] [Full Text] [Related]

  • 40. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism.
    Yano S, Sugimoto T, Tsukamoto T, Chihara K, Kobayashi A, Kitazawa S, Maeda S, Kitazawa R.
    Kidney Int; 2000 Nov 12; 58(5):1980-6. PubMed ID: 11044218
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.